Enduring undetectable MRD and updated outcomes in relapsed/refractory CLL after fixed-duration venetoclax-rituximab
Seymour, John F., Kipps, Thomas J., Eichhorst, Barbara F., D'Rozario, James, Owen, Carolyn J., Assouline, Sarit, Lamanna, Nicole, Robak, Tadeusz, de la Serna, Javier, Jaeger, Ulrich, Cartron, Guillaume, Montillo, Marco, Mellink, Clemens, Chyla, Brenda, Panchal, Anesh, Lu, Tong, Wu, Jenny Q., Jiang, Yanwen, Lefebure, Marcus, Boyer, Michelle, Kater, Arnon P.
Published in Blood (25.08.2022)
Published in Blood (25.08.2022)
Get full text
Journal Article
Evaluation and Clinical Analyses of Downstream Targets of the Akt Inhibitor GDC-0068
YIBING YAN, SERRA, Violeta, WAGLE, Marie-Claire, WU, Jenny Q, WONGCHENKO, Matthew, HAMPTON, Garret, RAMAKRISHNAN, Vanitha, LACKNER, Mark R, SAURA, Cristina, RODA, Desamparados, CERVANTES, Andrés, TABERNERO, Josep, PRUDKIN, Ludmila, PATEL, Premal, BASELGA, José, SCALTRITI, Maurizio, MURLI, Sumati, RODRIGUEZ, Olga, GUZMAN, Marta, SAMPATH, Deepak, NANNINI, Michelle, YUANYUAN XIAO
Published in Clinical cancer research (15.12.2013)
Published in Clinical cancer research (15.12.2013)
Get full text
Journal Article
Abstract 2017: Development of ultrasensitive Singulex immunoassays for CCL3 and CCL4, important biomarkers for the BTK inhibitor studies
Wu, Jenny Q., Burton, Luciana, Raja, Rajiv, McCaffery, Ian, Penuel, Elicia, Darbonne, Walter
Published in Cancer research (Chicago, Ill.) (01.08.2015)
Published in Cancer research (Chicago, Ill.) (01.08.2015)
Get full text
Journal Article